1-5 of 5
Inge Marie Svane
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A021: A cancer immunotherapy modality based on dendritic cell reprogramming in vivo

Ervin Ascic, Fritiof Åkerström, Malavika Sreekumar Nair, André Rosa, Ilia Kurochkin, Olga Zimmermannova, Xavier Catena, Nadezhda Rotankova, Charlotte Veser, Michal Rudnik, Tommaso Ballocci, Tiffany Schärer, Xiaoli Huang, Maria de Rosa Torres, Emilie Renaud, Marta Velasco Santiago, Özcan Met, David Askmyr, Malin Lindstedt, Lennart Greiff, Laure-Anne Ligeon, Irina Agarkova, Inge Marie Svane, Cristiana Pires, Fábio Fiúza Rosa, Carlos-Filipe Pereira
Journal: Cancer Immunology Research
Cancer Immunol Res (2024) 12 (10_Supplement): A021.
https://doi.org/10.1158/2326-6074.TUMIMM24-A021
Published: 18 October 2024
View article titled, Abstract A021: A cancer immunotherapy modality based on dendritic cell reprogramming <em>in vivo</em>
Journal Articles

Coexisting Alterations of MHC Class I Antigen Presentation and IFNγ Signaling Mediate Acquired Resistance of Melanoma to Post–PD-1 Immunotherapy

Morten Nielsen, Mario Presti, Zsofia Sztupinszki, Agnete Witness Præst Jensen, Arianna Draghi, Christopher Aled Chamberlain, Aimilia Schina, Christina Westmose Yde, John Wojcik, Zoltan Szallasi, Michael Douglas Crowther, Inge Marie Svane, Marco Donia
Journal: Cancer Immunology Research
Cancer Immunol Res (2022) 10 (10): 1254–1262.
https://doi.org/10.1158/2326-6066.CIR-22-0326
Published: 04 October 2022
View article titled, Coexisting Alterations of MHC Class I Antigen Presentation and IFNγ Signaling Mediate Acquired Resistance of Melanoma to Post–PD-1 Immunotherapy
Open the PDF for Coexisting Alterations of MHC Class I Antigen Presentation and IFNγ Signaling Mediate Acquired Resistance of Melanoma to Post–PD-1 Immunotherapy in another window
Includes: Supplementary data
Journal Articles

Abstract A14: Neoepitope-specific CD8+ T cells in adoptive T-cell transfer

Nikolaj Pagh Kristensen, Christina Heeke, Siri A. Tvingsholm, Anne-Mette Bjerregaard, Arianna Draghi, Amalie Kai Bentzen, Rikke Andersen, Marco Donia, Inge Marie Svane, Sine Reker Hadrup
Journal: Cancer Immunology Research
Cancer Immunol Res (2020) 8 (3_Supplement): A14.
https://doi.org/10.1158/2326-6074.TUMIMM19-A14
Published: 02 March 2020
View article titled, Abstract A14: Neoepitope-specific CD8+ T cells in adoptive T-cell transfer
Journal Articles

MERTK Acts as a Costimulatory Receptor on Human CD8+ T Cells

Marlies J.W. Peeters, Donata Dulkeviciute, Arianna Draghi, Cathrin Ritter, Anne Rahbech, Signe K. Skadborg, Tina Seremet, Ana Micaela Carnaz Simões, Evelina Martinenaite, Hólmfridur R. Halldórsdóttir, Mads Hald Andersen, Gitte Holmen Olofsson, Inge Marie Svane, Lene Juel Rasmussen, Özcan Met, Jürgen C. Becker, Marco Donia, Claus Desler, Per thor Straten
Journal: Cancer Immunology Research
Series: Author Choice
Cancer Immunol Res (2019) 7 (9): 1472–1484.
https://doi.org/10.1158/2326-6066.CIR-18-0841
Published: 03 September 2019
View article titled, MERTK Acts as a Costimulatory Receptor on Human CD8<sup>+</sup> T Cells
Open the PDF for MERTK Acts as a Costimulatory Receptor on Human CD8<sup>+</sup> T Cells in another window
Includes: Supplementary data
Journal Articles

T-cell Responses in the Microenvironment of Primary Renal Cell Carcinoma—Implications for Adoptive Cell Therapy

Rikke Andersen, Marie Christine Wulff Westergaard, Julie Westerlin Kjeldsen, Anja Müller, Natasja Wulff Pedersen, Sine Reker Hadrup, Özcan Met, Barbara Seliger, Bjarne Kromann-Andersen, Thomas Hasselager, Marco Donia, Inge Marie Svane
Journal: Cancer Immunology Research
Cancer Immunol Res (2018) 6 (2): 222–235.
https://doi.org/10.1158/2326-6066.CIR-17-0467
Published: 31 January 2018
View article titled, T-cell Responses in the Microenvironment of Primary Renal Cell Carcinoma—Implications for Adoptive Cell Therapy
Open the PDF for T-cell Responses in the Microenvironment of Primary Renal Cell Carcinoma—Implications for Adoptive Cell Therapy in another window
Includes: Supplementary data